BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36656928)

  • 1. Heritable defects in telomere and mitotic function selectively predispose to sarcomas.
    Ballinger ML; Pattnaik S; Mundra PA; Zaheed M; Rath E; Priestley P; Baber J; Ray-Coquard I; Isambert N; Causeret S; van der Graaf WTA; Puri A; Duffaud F; Le Cesne A; Seddon B; Chandrasekar C; Schiffman JD; Brohl AS; James PA; Kurtz JE; Penel N; Myklebost O; Meza-Zepeda LA; Pickett H; Kansara M; Waddell N; Kondrashova O; Pearson JV; Barbour AP; Li S; Nguyen TL; Fatkin D; Graham RM; Giannoulatou E; Green MJ; Kaplan W; Ravishankar S; Copty J; Powell JE; Cuppen E; van Eijk K; Veldink J; Ahn JH; Kim JE; Randall RL; Tucker K; Judson I; Sarin R; Ludwig T; Genin E; Deleuze JF; ; Haber M; Marshall G; Cairns MJ; Blay JY; ; Thomas DM; Tattersall M; Neuhaus S; Lewis C; Tucker K; Carey-Smith R; Wood D; Porceddu S; Dickinson I; Thorne H; James P; Ray-Coquard I; Blay JY; Cassier P; Le Cesne A; Duffaud F; Penel N; Isambert N; Kurtz JE; Puri A; Sarin R; Ahn JH; Kim JE; Ward I; Judson I; van der Graaf W; Seddon B; Chandrasekar C; Rickar R; Hennig I; Schiffman J; Randall RL; Silvestri A; Zaratzian A; Tayao M; Walwyn K; Niedermayr E; Mang D; Clark R; Thorpe T; MacDonald J; Riddell K; Mar J; Fennelly V; Wicht A; Zielony B; Galligan E; Glavich G; Stoeckert J; Williams L; Djandjgava L; Buettner I; Osinki C; Stephens S; Rogasik M; Bouclier L; Girodet M; Charreton A; Fayet Y; Crasto S; Sandupatla B; Yoon Y; Je N; Thompson L; Fowler T; Johnson B; Petrikova G; Hambridge T; Hutchins A; Bottero D; Scanlon D; Stokes-Denson J; Génin E; Campion D; Dartigues JF; Deleuze JF; Lambert JC; Redon R; Ludwig T; Grenier-Boley B; Letort S; Lindenbaum P; Meyer V; Quenez O; Dina C; Bellenguez C; Le Clézio CC; Giemza J; Chatel S; Férec C; Le Marec H; Letenneur L; Nicolas G; Rouault K
    Science; 2023 Jan; 379(6629):253-260. PubMed ID: 36656928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.
    DeBoy EA; Nicosia AM; Liyanarachchi S; Iyer SS; Shah MH; Ringel MD; Brock P; Armanios M
    Am J Hum Genet; 2024 Jun; 111(6):1114-1124. PubMed ID: 38688277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Truncating Germline Mutation of
    He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
    Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
    [No Abstract]   [Full Text] [Related]  

  • 4. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
    Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
    Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline study points to sarcoma pathways.
    Mandelker D; Ladanyi M
    Science; 2023 Jan; 379(6629):238-239. PubMed ID: 36656937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POT1 loss-of-function variants predispose to familial melanoma.
    Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
    Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline
    Jouenne F; Chauvot de Beauchene I; Bollaert E; Avril MF; Caron O; Ingster O; Lecesne A; Benusiglio P; Terrier P; Caumette V; Pissaloux D; de la Fouchardière A; Cabaret O; N'Diaye B; Velghe A; Bougeard G; Mann GJ; Koscielny S; Barrett JH; Harland M; Newton-Bishop J; Gruis N; Van Doorn R; Gauthier-Villars M; Pierron G; Stoppa-Lyonnet D; Coupier I; Guimbaud R; Delnatte C; Scoazec JY; Eggermont AM; Feunteun J; Tchertanov L; Demoulin JB; Frebourg T; Bressac-de Paillerets B
    J Med Genet; 2017 Sep; 54(9):607-612. PubMed ID: 28592523
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms.
    Lim TL; Lieberman DB; Davis AR; Loren AW; Hausler R; Bigdeli A; Li Y; Powers J; Raper A; Regeneron Genetics Center ; Carty SA; Nathanson KL; Bagg A; Hexner EO; Maxwell KN; Morrissette JJD; Babushok DV
    Leukemia; 2022 Jan; 36(1):283-287. PubMed ID: 34193977
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
    Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
    JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heritable Defects in Mitotic and Telomere Function Confer Sarcoma Risk.
    Cancer Discov; 2023 Mar; 13(3):529. PubMed ID: 36705478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of POT1 tumor predisposition syndrome: Tumor prevalence in a clinically diverse hereditary cancer cohort.
    Herrera-Mullar J; Fulk K; Brannan T; Yussuf A; Polfus L; Richardson ME; Horton C
    Genet Med; 2023 Nov; 25(11):100937. PubMed ID: 37466057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based analysis of
    Simonin-Wilmer I; Ossio R; Leddin EM; Harland M; Pooley KA; Martil de la Garza MG; Obolenski S; Hewinson J; Wong CC; Iyer V; Taylor JC; Newton-Bishop JA; Bishop DT; Cisneros GA; Iles MM; Adams DJ; Robles-Espinoza CD
    J Med Genet; 2023 Jul; 60(7):692-696. PubMed ID: 36539277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
    Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
    Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas.
    Chan SH; Lim WK; Ishak NDB; Li ST; Goh WL; Tan GS; Lim KH; Teo M; Young CNC; Malik S; Tan MH; Teh JYH; Chin FKC; Kesavan S; Selvarajan S; Tan P; Teh BT; Soo KC; Farid M; Quek R; Ngeow J
    Sci Rep; 2017 Sep; 7(1):10660. PubMed ID: 28878254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in shelterin complex genes are associated with familial glioma.
    Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
    J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.